Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2000-12-11
2002-07-23
Lateef, Marvin M. (Department: 3737)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C424S900000
Reexamination Certificate
active
06423007
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to ultrasonic imaging, and more particularly relates to methods for measuring blood flow rate and perfusion employing ultrasound contrast agents.
BACKGROUND OF THE INVENTION
The accurate measurement of blood flow and blood perfusion is of great clinical importance for evaluating physiologic function and clinical conditions. Noninvasive Doppler sonography has been used to provide information on blood velocity and techniques have been developed to estimate volumetric blood flow rates from Doppler velocity measurements. Measurement of volumetric blood flow using traditional Doppler generally requires the determination of vessel size, beam/vessel angle and some estimate of the spatial variations in velocity. These requirements limit the accuracy of volumetric flow rate assessments because of the many sources of error in the velocity estimation using Doppler methods, such as errors in the estimation of vessel diameter and beam/vessel angle.
Ultrasonic contrast agents, which most commonly take the form of encapsulated gaseous micro-bubbles, which scatter ultrasound effectively, have been demonstrated to enhance ultrasonic images of blood and Doppler signals. With recent improvements in their ability to persist over longer periods of time, ultrasonic contrast agents hold great potential for improved blood flow and perfusion measurements in local tissue regions and organs. As their interactions with ultrasound are radically different from blood or soft tissue, the application of ultrasonic contrast agents opens new ground for developing new and better methods for quantification and characterization of fluid flow.
Ultrasound contrast agents can be used as blood volume contrast agents because they become distributed within the vascular space, travel at the same velocity as the blood flow rate or velocity, and remain relatively stable in the body during clinical observation periods. These characteristics provide the potential for mean flow rate estimation based on the indicator dilution principle using the contrast time-video intensity curve in ultrasonic images following a bolus injection. Such a process is described in the article “Mathematical Modeling of the Dilution Curves for Ultrasonic Contrast Agents,” by C. M. Sehgal et al., J. Ultrasound Med., 16:471-479, 1997. However, current ultrasound methods that use the time-intensity curve in ultrasonic images following a bolus injection of a contrast medium are somewhat limited at present because 1) the interaction of ultrasound with contrast agents is not well understood; 2) the lack of knowledge of the number concentration of contrast agent and the rate of delivery, sometimes referred to as the “input function”; and 3) video intensity in ultrasonic images is a nonlinear conversion of returned echo amplitude from scatterers. Thus, improved methods of flow rate measurement using such contrast agents are required.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide improved methods for determining the concentration of contrast agents in a fluid.
In accordance with the present invention, a method of determining the concentration of a contrast agent in a fluid in a region is provided which includes acquiring backscatter data from the region; extracting spectral parameters from the backscatter data; and estimating a contrast agent concentration using at least one spectral parameter and a predetermined distribution function for the contrast agent.
Preferably, the spectral parameter is derived from a linear regression of spectral data as a function of frequency.
Also in accordance with the invention, a method of calculating the function C<r
2
> is provided, where C is the concentration of contrast agent particles and <r
2
> is the mean of the radius squared of contrast agent particles in a region of a fluid. The method includes acquiring backscatter data from the region; extracting at least one spectral parameter from the RF backscatter data; and estimating the function C<r
2
> using the spectral parameters.
The methods described can be further enhanced by spectrum analysis procedures applied to radio-frequency (RF) echo signals (backscatter) received from contrast agent particles. The computed spectra can be analyzed with linear regression procedures to derive a spectral parameter, such as an intercept value, that is proportional to C<r
2
> where C is the concentration of contrast agent particles and <r
2
> is the mean value of their squared radii.
REFERENCES:
patent: 4858124 (1989-08-01), Lizzi et al.
patent: 4932414 (1990-06-01), Coleman et al.
patent: 5685310 (1997-11-01), Porter
patent: 5732707 (1998-03-01), Widder et al.
patent: 5733527 (1998-03-01), Schutt
patent: 5746209 (1998-05-01), Yost et al.
patent: 5846517 (1998-12-01), Unger
patent: 5860931 (1999-01-01), Chandler
patent: 5976501 (1999-11-01), Jablonski
patent: 6110120 (2000-08-01), Holley et al.
patent: 6132377 (2000-10-01), Bolorforosh et al.
patent: 6159153 (2000-12-01), Dubberstein et al.
patent: 6176829 (2001-01-01), Vilkomerson
patent: 6193663 (2001-02-01), Napolitano et al.
patent: 6213951 (2001-04-01), Krishnan et al.
Deng et al., “Imaging and Spectrum Analysis of Contrast Agents in theIn VivoRabbit Eye Using Very-High-Frequency Ultrasound”, Ultrasound in Med & Biol. vol. 24, No. 3, pp. 383-394, 1998.
Deng Cheri Xiaoyu
Lizzi Frederic Louis
Imam Ali M.
Lateef Marvin M.
Riverside Research Institute
LandOfFree
Ultrasonic systems and methods for contrast agent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ultrasonic systems and methods for contrast agent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultrasonic systems and methods for contrast agent... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2884206